NCT00914017View on ClinicalTrials.gov

Statins and Breast Cancer Biomarkers

PHASE2UnknownINTERVENTIONAL
Enrollment

100

Participants

Timeline

Start Date

January 31, 2005

Primary Completion Date

December 31, 2010

Conditions
Breast Cancer
Interventions
DRUG

Atorvastatin

Atorvastatin, 40 mg daily for 1 year

DRUG

Placebo

sugar pill daily for 1 year

Trial Locations (7)

19718

RECRUITING

Delaware Christiana Care CCOP, Helen F. Graham Cancer Center, Newark

27534

RECRUITING

Southeastern Medical Oncology Center, Goldsboro

27705

RECRUITING

Duke University, Durham

89106

RECRUITING

Southern Nevada Cancer Research Foundation, Las Vegas

94143

RECRUITING

University of California, San Francisco, San Francisco

02115

RECRUITING

Dana Farber Cancer Institute, Boston

05405

RECRUITING

Vermont Cancer Center, Burlington

Sponsors
All Listed Sponsors
collaborator

Breast Cancer Research Foundation

OTHER

collaborator

Cancer and Leukemia Group B

NETWORK

lead

University of Vermont

OTHER